免疫功坊股份有限公司 IMMUNWORK
  • ( EN )
    • EN
    • 繁中
    CLOSE
  • About Us
    • Back
    • Overview
    • Founder
    • Executives
    • Scientific Advisors
    • Board of directors
  • Technologies
    • Back
    • Overview
    • T-ETMPharmaceuticals
    • Multi-arm linkers
    • Packed multi-arm linkers
    • Fatty acid bundles
  • Products
    • Back
    • Overview
    • TE-8105
    • TE-8214
    • TE-6168
    • TE-8035
  • News&Honors
  • Contact Us
  • ( English )
    • Back
    • English
    • 繁體中文
  • Copyright © 2017 MIRACLE

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies

Congratulations to our founder, Dr. Tse-Wen Chang, the inventor of Xolair.
We are thrilled to learn that Xolair's potential benefits are extending to more patients, especially those with food allergies.
 
The website link: https://www.businesswire.com/news/home/20240215550080/en/FDA-Approves-Xolair-as-First-and-Only-Medicine-for-Children-and-Adults-With-One-or-More-Food-Allergies
 
Back to the top

Immunwork, Inc., a wholly owned subsidiary of T-E Pharma Holding, a Cayman Island company.

Address: Room C520, Building C, No. 99, Lane 130, Sec. 1, Academia Rd,, Nangang District, Taipei City, Taiwan R.O.C. 115
Email: bd@immunwork.com or service@immunwork.com
Phone: +886-2-2651-2268
Design assisted by WebTech Webpage design
go top